🏅 FDA Orphan Designation

Ucephan

Benzoate and phenylacetate

Manufacturer: ImmunexImmunex

Indicated for:

OBSOLETE: Non-pore-loop channelopathy due to Cl- channel skeletal muscle Clc1 anomalyOrphan

FDA-Approved Indications (1)

OBSOLETE: Non-pore-loop channelopathy due to Cl- channel skeletal muscle Clc1 anomalyOrphan Designation

💙 Support Programs

View all →

Ucephan

ImmunexImmunex

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.